[Edaily] 'Stem Cell Breast Augmentation' Helps Boost Body Line Volume

​

​

​

​

​

​

[Edaily Reporter Lee Soon-yong] With the emergence of various surgical options for breast augmentation, implant insertion and fat grafting have established themselves as the two major procedures. Recently, stem cell breast augmentation, which utilizes the patient's own natural fat tissue to fill in 부족한 breast volume instead of inserting artificial implants, is gaining popularity.

No matter how close the shape and feel of an implant are to the natural breast, it is nearly impossible to replicate the feel of the original. Some patients also experience the side effect of capsular contracture, where the area around the implant hardens. The U.S. Food and Drug Administration (FDA) recommends regular breast examinations, as side effects such as capsular contracture, implant rupture, and rippling (the outer shell of the implant being palpable) cannot be ruled out.

On the other hand, those who undergo autologous fat transplantation can be free from such concerns. Among women who want to add breast volume but do not want it to look like they have had surgery, stem cell breast augmentation is sometimes considered an "open secret."

Autologous fat grafting emerged in the early 2000s and received an explosive response among women seeking natural-looking volume. Furthermore, since it also helped to smooth out excess fat, achieving the dream S-line figure was only a matter of time. However, it reached a limit with a low survival rate of 10–20%, meaning the fat tissue absorbed into the body and actually survives after the procedure. Taking this into account, injecting excessive amounts of fat could lead to necrosis or calcification, causing secondary problems and causing its popularity to wane.

However, with the introduction of an upgraded version of stem cell breast augmentation in 2008, these drawbacks were improved, and it is once again capturing the attention of women. It is the same as conventional fat grafting up to the point of harvesting fat from areas such as the abdomen and thighs. The difference lies in the fact that fat-derived adult stem cells are extracted, mixed with already purified fat cells in an appropriate ratio, and injected into the breasts.

The person who researched this and established substantial data is Shin Dong-jin, the representative director of SC301 Clinic. He began researching the integration of stem cells and cosmetic procedures in 2007. Based on this, he accumulated details to improve engraftment rates, successfully raising them to the 70% range, and published these findings in an academic journal of Shandong University School of Medicine in China from 2012 to 2015. He standardized previously inconsistent procedure methods and produced reliable clinical data.

Director Shin introduced the procedure, stating, “Stem cell breast augmentation minimizes fat loss, allowing for satisfactory results without side effects with just a single surgery. Compared to implant insertion, there is absolutely no concern regarding side effects such as capsular contracture, and it satisfies women with a natural volume that looks as if no surgery was performed.”

Above all, the clinic is increasing patient satisfaction by achieving successful surgical results even in thin women. In Korean society, where dieting has become commonplace, a significant number of women not only have limited fat available for harvesting but also tend to have low engraftment rates. SC301 Clinic provides thorough pre- and post-operative care to ensure that women with these handicaps can receive stem cell breast augmentation procedures in optimal condition.

In such cases, surgery cannot be performed immediately. First, a high-quality diet is used to create the conditions necessary to harvest healthy fat cells. The goal is to help the patient gain weight in a healthy way, rather than inducing obesity. Since the fat cells are subsequently removed from the affected area, there is no need to worry about excessive weight gain. During the main procedure, patented capsules are administered to enhance the survival rate, and afterwards, oxygen chamber care is used to encourage the fat cells to engraft successfully. 

Director Shin Dong-jin pointed out that underdeveloped breasts have tough and dense tissue, requiring a more cautious approach to the procedure. However, simply transplanting stem cells does not guarantee a successful outcome. Significant differences in results can arise depending on the know-how to extract as many stem cells as possible without damage, extraction equipment that minimizes high heat and vibration, and the surgeon's technique to shorten the fat grafting time through rapid hand movements. For instance, stem cells must be isolated within a very short time and rapidly injected into each tissue layer of the breast in the golden ratio to increase the number of viable cells and improve the engraftment rate.

This clinic utilizes state-of-the-art equipment such as TGI and Cell3 to inject 3000 million to 1 million stem cells, and creates a breast condition that enhances engraftment rates through pre-operative care. In addition, it establishes a condition that maximizes the retention of stem cells through pre- and post-operative dietary, exercise, and drug therapies. Thanks to this high level of treatment technology, the clinic was awarded the '2016 Medical Consumer Satisfaction Award' last month. 

Director Shin Dong-jin pointed out, “The majority of clinics promoting stem cell plastic surgery are merely going through the motions without being equipped with stem cell extraction equipment,” adding, “Pre- and post-operative care is also a mess, making it no different from conventional fat grafting, so caution is advised.”

View original article

http://www.edaily.co.kr/news/NewsRead.edy?SCD=JG61&newsid=03404646612785368&DCD=A00706&OutLnkChk=Y